Ginkgo Bioworks Holdings (DNA)Erste Asset Management GmbH added to its stake +200K shares
Erste Asset Management GmbH added to its stake in Ginkgo Bioworks Holdings, per its Q3 2025 13F.
- 2.2M
- Shares reported · +200K vs prior quarter
- 0.28%
- Disclosed portfolio weight
- $29.1M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Nov 12, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
- Dec 18, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On December 18, 2025, Ginkgo Bioworks Holdings, Inc. (the “Company”) announced that Dr. Reshma Shetty, the Company’s President, Chief Operating Officer, and member of the Board of Directors, will transition her Chief Operating Officer duties to Jennifer Wipf and Dr. Jason Kelly, the Company’s Chief Executive Officer, on January 1, 2026.”
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 26, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Ginkgo Bioworks Holdings
For Ginkgo Bioworks Holdings, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DNA page.
How this filing works
Other disclosures at Ginkgo Bioworks Holdings
- SEC Form 4Oct 7, 2026
- SEC Form 144Oct 5, 2026
- USAspending.gov award recordAug 5, 2026
- SEC Form 13F-HRFeb 11, 2026
- SEC Form 4Sep 10, 2025
- SEC Form 4Sep 10, 2025
Everything OQRO holds on this company is on its DNA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data